Clinical trial
Interleukin-15 to Promote Post-ART Control of HIV
NCT07145164 is registered in ClinicalTrials.gov with Michael Peluso, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-15 to Promote Post-ART Control of HIV
- Lead sponsor
- Michael Peluso, MD
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- August 19, 2025
- Completion date
- December 31, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv